Duration of treatment in oncology clinical trials: does the duration change when the same drug moves from the experimental arm to the control arm?

HIGHLIGHTS

• who: A. Haslam from the Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, USA have published the research: Duration of treatment in oncology clinical trials: does the duration change when the same drug moves from the experimental arm to the control arm?, in the Journal: (JOURNAL)
• what: The median duration of treatment in the study initially testing the drug was 6.0 months (range: 2.2-12.7 months), whereas the median duration of treatment when the same drug was used as a comparator was 4.9 months (range: 1.712 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.